Risk of Gynecomastia with Users of Proton Pump Inhibitors

ConclusionThis large retrospective cohort study suggests that patients who used PPIs are at higher risk of developing gynecomastia. Clinicians may want to convey this information to male patients who require long ‐term PPI therapy.This article is protected by copyright. All rights reserved.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - March 12, 2019 Category: Drugs & Pharmacology Authors: Bonnie He, Bruce Carleton, Mahyar Etminan Tags: Brief Report Source Type: research